Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 10412906Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2025Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2025 award categories
- ENGINEERING (ALL TYPES)
NIH Funding · FY2024
Linked Award Amount
$1.2M
Full award amounts, FY2024
Award Records
2
Records listing this PI
Award-Linked Rank
#11,774
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2024 award records by amount
NIH award records listing Curtis Lisante Cetrulo as a PI. Multi-PI records show the full award amount for context.
- 5R01DK132576-03R01Precise targeting of T1D specific T cells using CAR and peptide-MHC chimeric antigen ligands$769.7Kaward amount
- 5R01EB028782-04R01Genetic-engineered control of the immunogeneic state of vascular composite allografts during preservation$449.9Kaward amount
Award organizations
Organizations that administered FY2024 awards listing Curtis Lisante Cetrulo as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardBoston University
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024R01 Grant Holder
- 2025Multi-Institutional ResearchAwards at 2 institutions
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Curtis Lisante Cetrulo.